A consortium of leading researchers and clinicians from across the UK working together to understand and improve long-term health outcomes for patients who have been in hospital with confirmed or suspected COVID-19.
As we emerge from the first wave of the pandemic, we have new insights into the sudden onset phase of this disease but there is very little information concerning the long-term effects of COVID-19 and what the ongoing medical, psychological and rehabilitation needs for this group of patients will be to enable them to make as full a recovery as possible.
To address this gap in our understanding, PHOSP-COVID has been set up and funded as a long term research study to recruit 10,000 patients who have been hospitalised with COVID-19. Over the course of a year, clinical assessments will track patients to gain a comprehensive picture of the impact COVID-19 has had on longer term health outcomes across the UK.
The PHOSP-COVID team will then develop trials of new strategies for clinical care, including personalised treatments for groups of patients based on the particular disease characteristics they show as a result of having COVID-19 to improve their long term health.
